

E-cadherin is critical for the maintenance of tissue architecture and is a major component of adherens junctions. Its role in tumour development is well established, with many human carcinomas exhibiting E-cadherin loss at the invasive front. In many invasive carcinomas, the mechanisms leading to the loss of E-cadherin remains elusive. Here, we hypothesize that mechanisms of protein quality control play a key role in E-cadherin regulation. As a cell model system, we used CHO cells stably expressing E-cadherin germline missense mutations R749W and E757K, which are associated with hereditary diffuse gastric cancer. An abnormal pattern of E-cadherin expression was observed, with protein accumulating mainly in the endoplasmic reticulum (ER). We demonstrated that E-cadherin missense mutants are subjected to Endoplasmic Reticulum Quality Control (ERQC) and that their loss is due to ER-associated degradation. Treatment of these mutant cells with specific chemical chaperones restored E-cadherin to the cell membrane and rescued its function. We show that ERQC plays a major role in E-cadherin regulation and propose that overcoming this regulation may represent an approach to rescue E-cadherin expression and functionality in cancer. © The Author 2008. Published by Oxford University Press. All rights reserved.
| EMTREE drug terms: | uvomorulin |
|---|---|
| EMTREE medical terms: | animal cellarticleCHO cellcontrolled studyendoplasmic reticulumendoplasmic reticulum quality controlfemalegene lossgenetic associationmissense mutationnonhumanpriority journalprotein aggregationprotein degradationprotein expressionprotein functionprotein localizationregulatory mechanismstomach cancer |
| MeSH: | AnimalsCadherinsCHO CellsCollagenCricetinaeCricetulusDrug CombinationsEndoplasmic ReticulumHumansImmunoprecipitationLamininMolecular ChaperonesMutation, MissenseNeoplasmsProteoglycansReverse Transcriptase Polymerase Chain ReactionUbiquitination |
uvomorulin, 112956-45-3;
Cadherins; Collagen, 9007-34-5; Drug Combinations; Laminin; matrigel, 119978-18-6; Molecular Chaperones; Proteoglycans
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Fonds Wetenschappelijk Onderzoek | ||
| Fundação para a Ciência e a Tecnologia See opportunities | SFRH/BD/15239/2004 |
Fundac¸ão para a Ciência e Tecnologia, Portugal (PTDC/ SAU-OBD/64319/2006, SFRH/BD/15239/2004); National Fund for Scientific Research, Flanders (FWO).
Suriano, G.; IPATIMUP, Institute of Molecular Pathology and Immunology, University of Porto, Rua Dr. Roberto Frias s/n, Portugal;
© Copyright 2008 Elsevier B.V., All rights reserved.
© MEDLINE® is the source for the MeSH terms of this document.